1. Home
  2. ADMA vs NGVT Comparison

ADMA vs NGVT Comparison

Compare ADMA & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$7.92

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Ingevity Corporation

NGVT

Ingevity Corporation

HOLD

Current Price

$68.94

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
NGVT
Founded
2004
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
ADMA
NGVT
Price
$7.92
$68.94
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$25.67
$72.50
AVG Volume (30 Days)
6.0M
219.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.10
EPS
0.19
1.66
Revenue
$42,219,783.00
$1,167,600,000.00
Revenue This Year
$27.46
$3.63
Revenue Next Year
$22.11
$0.50
P/E Ratio
$43.03
$41.42
Revenue Growth
43.85
N/A
52 Week Low
$7.21
$39.74
52 Week High
$22.37
$79.29

Technical Indicators

Market Signals
Indicator
ADMA
NGVT
Relative Strength Index (RSI) 30.12 45.38
Support Level $7.34 $63.60
Resistance Level $16.02 $77.72
Average True Range (ATR) 0.44 2.09
MACD 0.02 -0.47
Stochastic Oscillator 30.69 37.53

Price Performance

Historical Comparison
ADMA
NGVT

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

Share on Social Networks: